Natco Pharma Shares Drop 3.5% as Supreme Court Lists Plea on Risdiplam Launch
Market Performance:Natco Pharma shares saw a sharp decline of 3.5% on October 14, trading at Rs 808.70 on NSE by 12:20 pm. The drop comes amid heightened legal developments surrounding the launch of Natco’s Risdiplam drug, attracting market attention.Main News:The Supreme Court has agreed to urge...
Easy & quick